Clinical Trials

74 enrolled

Colorectal Neoplasms

NCT06666803 2026-04-16

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

PDAC - Pancreatic Ductal Adenocarcinoma

NCT03348891 2026-04-14

MELANFα

Dermatologic

Melanoma

NCT05088395 2026-04-14

ALCINA4

2,050 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT02453620 2026-04-13

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

57 enrolled

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT06861244 2026-04-13

PNOC031

70 enrolled

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT06020651 2026-04-08

VICKI

39 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT07284589 2026-04-08

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

200 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT04412629 2026-04-06

Cabozantinib in High Grade Neuroendocrine Neoplasms

35 enrolled

Endocrine

High Grade Neuroendocrine Neoplasms

NCT06274515 2026-04-06

REMERGE

Phase 4 Recruiting

320 enrolled

Breast Neoplasms

NCT06618703 2026-04-06

BIChE-1

230 enrolled

CNS

Brain Neoplasms, Radiation Injuries

NCT04141462 2026-04-03

EX²TRICAN

613 enrolled

Neoplasms, Genetic Predisposition to Disease

NCT02613962 2026-04-01

MAPPYACTS

791 enrolled

Neoplasms, Recurrence

NCT02822404 2026-04-01

CysPed

42 enrolled

Kidney Diseases

NCT07054346 2026-04-01

LUTACT

Phase 1 Recruiting

45 enrolled

Phase 4 Not yet recruiting

Disease, Prostatic Neoplasms

NCT07490509 2026-04-01

DOSABEMA

235 enrolled

Breast Neoplasms

NCT02133222 2026-03-31

AMMAM

Phase 2 Active not recruiting

22 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT04067726 2026-03-31

TRIDENT

210 enrolled

Breast Neoplasms

NCT05981326 2026-03-31

NEOEPICURE

300 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT02867033 2026-03-30

ALTITUDES

628 enrolled

Sarcoma

Desmoid Tumors

NCT04167969 2026-03-27

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Phase 1 Recruiting

16 enrolled

Prostatic Neoplasms

NCT05754892 2026-03-27

COMETE-CARE

450 enrolled

Neoplasms

NCT06435546 2026-03-27

AdOTAC

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07276360 2026-03-27

HypoRTCx-UG

Phase EARLY_PHASE1 Terminated

278 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05204290 2026-03-24

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

1 enrolled

Neoplasms, Epidural Neoplasms

NCT05212272 2026-03-23

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

16 enrolled

CNS

Glioma

NCT03010124 2026-03-20

OvBIOMark

350 enrolled

Gynecologic

Ovarian Neoplasms

NCT05191940 2026-03-20

LAPC

30 enrolled

Pancreatic Neoplasms

NCT05595577 2026-03-20

PALS

110 enrolled

BreastLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05692635 2026-03-20

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Phase NA Active not recruiting

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03185039 2026-03-19

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

50 enrolled

Kidney Neoplasms

NCT03958747 2026-03-19

Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

20 enrolled

Phase NA Not yet recruiting

Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT07163507 2026-03-18

RICEPS-2

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07476781 2026-03-17

CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases

Meningeal Neoplasms

NCT01374620 2026-03-16

PAL-ANGI2

Phase 1 Completed

28 enrolled

Neoplasms

NCT04767568 2026-03-16

PREDICT-IRFC

400 enrolled

Colorectal Neoplasms

NCT06796114 2026-03-16

PREDICT-HCC

120 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07472387 2026-03-16

Andro-iGlio

40 enrolled

CNS

Glioblastoma

NCT00911911 2026-03-13

SPAM

66 enrolled

DermatologicGastrointestinalSarcoma

Breast Neoplasms

NCT01046487 2026-03-13

PALANGI3

Phase 1 Completed

26 enrolled

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT01647867 2026-03-13

MetLung

56 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07469319 2026-03-13

BISHOP

617 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT03249389 2026-03-12

CALCIOBS

146 enrolled

Breast Neoplasms

NCT03252912 2026-03-12

LCS Bio Sein

51 enrolled

MyeloidOther hematologic neoplasm

Breast Neoplasms

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT07465848 2026-03-12

PneumoTAV001

1,200 enrolled

Thoracic

Disease, Lung Neoplasms

NCT07463508 2026-03-11

TG-BIL

20 enrolled

Phase 1/2 Active not recruiting

Testicular Neoplasms

NCT04454528 2026-03-10

BreastVAX

27 enrolled